The economic burden of migraine to society

PharmacoEconomics

Volumn 13, Issue 6, 1998, Pages 667-676

  Ferrari, Michel D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; CONSULTATION; COST OF ILLNESS; DISABILITY; DRUG COST; EMERGENCY HEALTH SERVICE; EUROPE; HEALTH CARE COST; HOSPITAL COST; HUMAN; MIGRAINE; NORTH AMERICA; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; PRODUCTIVITY; REVIEW; TREATMENT PLANNING;

COST OF ILLNESS; HEALTH CARE COSTS; HUMANS; MIGRAINE DISORDERS;

EID: 0031835817     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199813060-00003     Document Type: Review

References (31)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 Suppl 7: 19-28
2. Edmeads J, Findlay H, Tugwell P, et al. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 1993; 20: 131-7
3. Streator SE, Shearer SW. Pharmacoeconomic impact of injectable sumatriptan on migraine-associated healthcare costs. Am J Manage Care 1996; 2: 139-43
4. Celentano DD, Stewart WF, Lipton RB, et al. Medication use and disability among migraineurs: a national probability sample survey. Headache 1992; 32: 223-8
5. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics 1992; 2 (1): 67-76
6. Stang PE, Osterhaus JT, Celentano DD, et al. Migraine: problems of healthcare. Neurology 1994; 44 Suppl. 4: S47-55
7. Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health 1992; 46: 443-6
8. van Roijen L, Essink-Bot M-L, Koopmanschap MA, et al. Societal perspective on the burden of migraine in the Netherlands. Pharmacoeconomics 1995; 7 (2): 170-9
9. Wong TW, Wong KS, Yu TS, et al. Prevalence of migraine and other headaches in Hong Kong. Neuroepidemiology 1995; 14: 82-91
10. Sakai F, Igarashi H. Epidemiology of migraine in Japan: a nationwide study. Cephalalgia 1997; 17: 15-22
11. Kaa KA, Carlson JA, Osterhaus JT. Emergency department resource use by patients with migraine and asthma in a health maintenance organization. Ann Pharmacother 1995; 29: 251-6
12. Micieli G. Suffering in silence. In: Edmeads J, editor. Migraine: a brighter future. Worthing: Cambridge Medical Publications, 1993: 1-7
13. Parry TG. The prevalence and costs of migraine in Australia. Kensington: University of New South Wales, 1992. Centre for Applied Economic Research (CAER) working paper no.: 1992/1
14. Björk S, Roos P. Economic aspects of migraine in Sweden. Lund: Institute for Health Economics, 1991. Working paper no.: 8
15. Blau JN, Drummond MF. Migraine. London: Office of Health Economics, 1991
16. Bloomberg Financial Markets. Electronic database. New York: LP Bloomberg, 1998
17. International Monetary Fund (IMF). International financial statistics. Vol. 11 (1). Washington, DC: IMF, 1998
18. O'Brien B, Goeree R, Streiner D. Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol 1994; 23: 1020-6
19. Clouse JC, Osterhaus JT. Healthcare resource use and costs associated with migraine in a managed Healthcare setting. Ann Pharmacother 1994; 28: 659-64
20. Cull RE, Wells NEJ, Miocevich ML. The economic cost of migraine. Br J Med Econ 1992; 2: 103-15
21. Láinez JM, Titus F, Cobaleda S, et al. Socioeconomic impact of migraine [abstract]. Funct Neurol 1996; 11: 133
22. Clarke CE, MacMillan L, Sondhi S, et al. Economic and social impact of migraine. Q J Med 1996; 89: 77-84
23. Stewart WF, Lipton RB, Celentano DD, et al. Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors. JAMA 1992; 267: 64-9
24. Stewart WF, Lipton RB, Simon D. Work-related disability: results from the American migraine study. Cephalalgia 1996; 16: 231-8
25. To T, Wu K. Health care utilization and disability of migraine: the Ontario health survey. Can J Public Health 1995; 86: 195-9
26. Stang PE, Osterhaus JT. Impact of migraine in the United States: data from the National Health Interview Survey. Headache 1993; 33: 29-35
27. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991; 37: 11-23
28. Göhel H, Petersen-Braun M. Why patients with primary headaches do not consult a doctor. In: Olesen J, editor. Headache classification and epidemiology. New York: Raven Press Ltd, 1994: 267-72
29. Huse DM, Oster G, Killen AR, et al. The economic costs of non-insulin dependent diabetes mellitus. JAMA 1989; 262: 2708-13
30. Lipton RB, Stewart WF, Von Korff M. The burden of migraine. A review of cost to society. Pharmacoeconomics 1994; 6 (3): 215-21
31. Sawyer J, Edmeads J, Lipton RB, et al. Clinical utility of a new instrument assessing migraine disability: the migraine disability assessment (MIDAS) questionnaire [abstract]. Neurology 1998; 50 Suppl. 4: A433-4